BMO Capital Markets initiated coverage on Hamilton Lane with a new price target
$HLNE
Investment Managers
Finance
BMO Capital Markets initiated coverage of Hamilton Lane with a rating of Outperform and set a new price target of $150.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/11/2025 | $166.00 | Buy | UBS |
| 11/6/2025 | $165.00 | Neutral → Buy | Goldman |
| 10/14/2025 | $181.00 | Perform → Outperform | Oppenheimer |
| 10/13/2025 | $150.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 10/3/2025 | $150.00 | Outperform | BMO Capital Markets |
| 9/18/2025 | $162.00 | Sell → Neutral | Goldman |
| 5/15/2025 | Outperform → Perform | Oppenheimer | |
| 1/21/2025 | $186.00 | Perform → Outperform | Oppenheimer |
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Cosette's Abbreviated New Drug Application (ANDA) for the first generic version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days of Competitive Generic Therapy (CGT) exclusivity. Cosette has commenced commercial shipments, triggering the 180 days of market exclusivity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216065234/en/ As the first approved generic of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic sus
Slate Asset Management ("Slate" or the "Firm"), a global investor and manager focused on essential real estate and infrastructure, and private markets investment management firm Hamilton Lane (NASDAQ:HLNE), announced today the acquisition of a majority equity stake in Cold-Link Logistics ("Cold-Link" or the "Company"), one of the ten largest privately-held cold storage platforms in North America. The acquisition further enhances Slate's position as a leading owner and operator of essential real estate and infrastructure globally in support of non-discretionary needs of day-to-day life. In addition to Slate and funds managed by Hamilton Lane, the acquisition was completed with the support of
CONSHOHOCKEN, Pa., Dec. 8, 2025 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today was named a "Best Place to Work in Money Management" by Pensions & Investments for the 14th consecutive year. Hamilton Lane is among a select group of firms to have earned this distinction every year since the program's inception in 2012. The annual survey and recognition program conducted by Pensions & Investments identifies the best employers in the money management industry based on workplace policies, practices, benefits and demographics. This year's recognition underscores Hamilton Lane's continued commitment to cultivating a collaborative, inclusive and
10-Q - Hamilton Lane INC (0001433642) (Filer)
8-K - Hamilton Lane INC (0001433642) (Filer)
8-K - Hamilton Lane INC (0001433642) (Filer)
UBS resumed coverage of Hamilton Lane with a rating of Buy and set a new price target of $166.00
Goldman upgraded Hamilton Lane from Neutral to Buy and set a new price target of $165.00
Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $181.00
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
3 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
CONSHOHOCKEN, Pa. and NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Leading private markets firm Hamilton Lane (NASDAQ:HLNE) and The Guardian Life Insurance Company of America® ("Guardian"), one of the nation's largest life insurers and a leading provider of employee benefits, today announced an innovative, long-term strategic partnership. Through this partnership, Hamilton Lane will manage Guardian's existing private equity portfolio of nearly $5 billion. Guardian will also commit to invest approximately $500 million per year in private equity for the next 10 years through Hamilton Lane. This commitment maintains Guardian's typical annual contribution to the asset class and supports its general a
-- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co
Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
CONSHOHOCKEN, Pa., Nov. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the second fiscal quarter ended September 30, 2025. The Company issued a full detailed presentation of its second quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on December 19, 2025 that will be paid on January 7, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fisca
- KAIO has been leading the tokenization of major institutional funds, expanding crypto-native access to regulated money markets and alternative investment strategies - The tokenization of Hamilton Lane SCOPE Fund on Sei's DeFi optimized design is expected to enhance accessibility for the fund's investors ABU DHABI, UAE, Oct. 15, 2025 /PRNewswire/ -- KAIO, the leading fully onchain infrastructure for regulated real-world assets (RWAs), today announced the expansion of its tokenized fund offerings on the Sei Network by bringing access to Hamilton Lane's (NASDAQ:HLNE) Senior Credit Opportunities Fund ("SCOPE") onchain, via HL SCOPE Access Fund1, for institutional and accredited inv
CONSHOHOCKEN, Pa., Oct. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the second fiscal quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 10:00 a.m. ET on November 4 to discuss the results for the second fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at lea